Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Long-Term Debt of $100.82 million for fiscal year 2024.
LIFECORE BIOMEDICAL, INC. \DE\ Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2024 | $100.82M | +19.7% |
| 2023 | $84.26M | -14.8% |
| 2023 | $98.90M | — |
| 2022 | $0.00 | -100.0% |
| 2022 | $79.60M | -35.9% |
| 2021 | $124.19M | +0.3% |
| 2021 | $123.83M | -24.9% |
| 2021 | $164.90M | +13.7% |
| 2021 | $145.05M | +76.9% |
| 2020 | $82.00M | -12.7% |
| 2020 | $93.92M | -7.3% |
| 2020 | $101.36M | +16.3% |
| 2019 | $87.19M | +133.4% |
| 2018 | $37.36M | -11.7% |
| 2017 | $42.30M | -8.0% |
| 2016 | $45.97M | +34.6% |
| 2015 | $34.17M | +20.7% |
| 2014 | $28.32M | -17.6% |
| 2013 | $34.37M | -14.7% |
| 2012 | $40.30M | +160.0% |
| 2011 | $15.50M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| November 30, 2024 | $110.53M | +20.0% | +4.7% |
| August 31, 2024 | $105.55M | +19.9% | +4.7% |
| May 31, 2024 | $100.82M | +19.7% | +4.7% |
| February 29, 2024 | $96.34M | -2.7% | +4.6% |
| November 30, 2023 | $92.08M | — | +4.6% |
| August 31, 2023 | $88.06M | -8.1% | +4.5% |
| May 31, 2023 | $84.26M | — | -14.9% |
| February 28, 2023 | $98.96M | +24.3% | — |
- LIFECORE BIOMEDICAL, INC. \DE\ showed an increase of +19.7% in Long-Term Debt compared to the prior fiscal year.
- Over the 2011–2024 period, LIFECORE BIOMEDICAL, INC. \DE\’s long-term debt has grown by 550.4% (from $15.50 million to $100.82 million).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2024 report (Form 10-K), filed with the SEC on August 26, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: